Skip to main content
. 2022 Nov 27;12:20366. doi: 10.1038/s41598-022-24315-1

Table 1.

Clinical data referred to CPTAC-CM public dataset.

Characteristic Distribution
Outcome
DF cases (%) 31 (72.1%)
non-DF cases (%) 12 (27.9%)
Gender
Male (%) 21 (48.8%)
Female (%) 22 (51.2%)
Tumor site
Trunk (%) 20 (46.6%)
Palms and (%) 1 (2.3%)
Extremities (abs.; %) 11 (25.6%)
Head & neck (%) 1 (2.3%)
Lymph nodes (%) 5 (11.6%)
Other (%) 5 (11.6%)
Stage
I (abs.; %) 6 (14.0%)
II (abs.; %) 27 (62.7%)
III (abs.; %) 10 (23.3%)
T
T0 (abs.; %) 2 (4.7%)
T1 (abs.; %) 3 (6.8%)
T2 (abs.; %) 10 (23.3%)
T3 (abs.; %) 6 (14.0%)
T4 (abs.; %) 22 (51.2%)
Age
Median (std.) 64.0 (14.9)

For categorical variables, percentage (%) counts are reported. For continuous values, the median and standard deviation (sd.) values are indicated.

The abbreviation DF stands for disease free. Among the five patients for which the tumor site has been labelled as ‘Other’, more detailed specifics about the tumor site were available online. For two of these patients, the primary site was specified to be unknown. The other three tumor sites were the left shoulder, the right shoulder and the IV toe of the left foot, respectively.